We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $751B
1-Year Est. Return 38.74%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+21.29%
1 Year Est. Return
+38.74%
3 Year Est. Return
+107.64%
5 Year Est. Return
+136.97%
10 Year Est. Return
+527.18%
AUM
$751B
AUM Growth
+$96.9B
Cap. Flow
+$16.8B
Cap. Flow %
2.23%
Top 10 Hldgs %
21.83%
Holding
3,591
New
136
Increased
2,145
Reduced
1,132
Closed
153
Avg Time Held
31.7 quarters
Top 10 Avg Time Held
19.9 quarters
Top 20 Avg Time Held
13.5 quarters

Top Buys

Rank Stock Value
1
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$2.6B
2
ABT icon
Abbott
ABT
+$1.29B
3
HD icon
Home Depot
HD
+$1.03B
4
DVN icon
Devon Energy
DVN
+$888M
5
PEP icon
PepsiCo
PEP
+$880M

Sector Composition

Rank Sector Weight
1 Technology 27.11%
2 Financials 10.61%
3 Healthcare 10.33%
4 Miscellaneous 9.93%
5 Industrials 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BHR icon
3326
Braemar Hotels & Resorts
BHR
$83.1M
$312K ﹤0.01%
144,233
-1,369
-0.9% -$3.28K
2021 Q2
20 quarters
ANTX icon
3327
AN2 Therapeutics
ANTX
$166M
$311K ﹤0.01%
+64,220
New +$276K
2026 Q2
0 quarters
ABOS icon
3328
Acumen Pharmaceuticals
ABOS
$155M
$307K ﹤0.01%
+115,099
New +$284K
2026 Q2
0 quarters
AGEN icon
3329
Agenus
AGEN
$346M
$304K ﹤0.01%
99,392
+84,392
+563% +$302K
2014 Q2
48 quarters
HNVR icon
3330
Hanover Bancorp
HNVR
$173M
$303K ﹤0.01%
13,006
– –
2025 Q3
3 quarters
CURI icon
3331
CuriosityStream
CURI
$166M
$300K ﹤0.01%
112,721
-29,828
-21% -$88.2K
2023 Q1
13 quarters
BARK icon
3332
BARK
BARK
$72.4M
$293K ﹤0.01%
29,358
-11,675
-28% -$109K
2021 Q3
19 quarters
GWRS icon
3333
Global Water Resources
GWRS
$234M
$291K ﹤0.01%
40,255
+5,683
+16% +$41.1K
2016 Q2
40 quarters
ACR icon
3334
ACRES Commercial Realty
ACR
$164M
$290K ﹤0.01%
16,317
– –
2025 Q2
4 quarters
OKUR icon
3335
OnKure Therapeutics
OKUR
$97.6M
$290K ﹤0.01%
+63,640
New +$273K
2026 Q2
0 quarters
BOXX icon
3336
Alpha Architect 1-3 Month Box ETF
BOXX
$14.6B
$290K ﹤0.01%
+2,477
New +$289K
2026 Q2
0 quarters
BTGO icon
3337
BitGo Holdings
BTGO
$862M
$287K ﹤0.01%
55,331
-11,031
-17% -$90.5K
2026 Q1
1 quarter
SKIN icon
3338
SkinHealth Systems
SKIN
$71.6M
$284K ﹤0.01%
410,382
-315,627
-43% -$241K
2021 Q2
20 quarters
VHI icon
3339
Valhi
VHI
$402M
$283K ﹤0.01%
19,323
+2,824
+17% +$39.8K
2021 Q2
20 quarters
VERI icon
3340
Veritone
VERI
$56.2M
$282K ﹤0.01%
205,648
+154,719
+304% +$296K
2024 Q4
6 quarters
FWONA icon
3341
Liberty Media Corporation Series A Common Stock
FWONA
$21.7B
$272K ﹤0.01%
+3,103
New +$255K
2026 Q2
0 quarters
CPSS icon
3342
Consumer Portfolio Services
CPSS
$205M
$268K ﹤0.01%
27,918
+3,988
+17% +$37K
2022 Q2
16 quarters
CNTN icon
3343
Canton Strategic Holdings
CNTN
$168M
$266K ﹤0.01%
+94,221
New +$298K
2026 Q2
0 quarters
ORBS icon
3344
Eightco Holdings
ORBS
$361M
$259K ﹤0.01%
+372,643
New +$335K
2026 Q2
0 quarters
UNCY icon
3345
Unicycive Therapeutics
UNCY
$114M
$257K ﹤0.01%
+54,842
New +$405K
2026 Q2
0 quarters
HYPR icon
3346
Hyperfine
HYPR
$98.7M
$257K ﹤0.01%
+190,235
New +$275K
2026 Q2
0 quarters
LCUT icon
3347
Lifetime Brands
LCUT
$219M
$255K ﹤0.01%
+29,845
New +$231K
2026 Q2
0 quarters
RDNW icon
3348
RideNow Group
RDNW
$193M
$254K ﹤0.01%
+38,200
New +$278K
2026 Q2
0 quarters
SMID icon
3349
Smith-Midland
SMID
$119M
$253K ﹤0.01%
8,726
+1,281
+17% +$39.9K
2024 Q2
8 quarters
VATE icon
3350
INNOVATE Corp
VATE
$98.5M
$253K ﹤0.01%
+13,538
New +$184K
2026 Q2
0 quarters

Similar funds

Charles Schwab's Q2 2026 Portfolio in Review

As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
  • Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
  • Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
  • Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
  • Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
  • Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
  • Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.